Browsing by Author/Editor/Contributor Tahir, Hasan

Jump to a point in the index:
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)TypeCat.
2019Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: Final 5 year efficacy and safety results from a phase 3 trialMease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Juergen; Hall, Stephen; GEUSENS, Piet ; Pellet, Pascale; Delicha, Eumorphia Maria; Pricop, Luminita; Mpofu, ShephardJournal ContributionM
2019Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: Final 5-year efficacy and safety results from the FUTURE 1 phase 3 trialTahir, Hasan; Mease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Rech, Juergen; Hall, Stephen; GEUSENS, Piet ; Pellet, Pascale; Delicha, Eumorphia Maria; Pricop, Luminita; Mpofu, ShephardJournal ContributionM
2018Efficacy and safety of ixekizumab at week 52 in biologic naive patients with active psoriatic arthritis (SPIRIT-P1)Lespessailles, Eric; Kirkham, Bruce; Nebro, Antonio Fernandez; Blanco, Ricardo; Strehblow, Christoph; Inciarte-Mundo, Jose; Porsdal, Vibeke; Garcia, Miriam; Kurzawa, Monika; Sapin, Christophe; GEUSENS, Piet ; Goupille, Philippe; Tahir, HasanJournal ContributionM
2018Secukinumab Provides Sustained Improvements in the Signs and Symptoms in Psoriatic Arthritis: Final 5 Year Efficacy and Safety Results from a Phase 3 TrialMease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Juergen; Hall, Stephen; GEUSENS, Piet ; Pascale, Pellet; Delicha, Evie Maria; Pricop, Luminita; Mpofu, ShephardJournal ContributionM
2017Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trialMease, Philip J.; Kavanaugh, Arthur; Reimold, Andreas; Tahir, Hasan; Rech, Juergen; Hall, Stephen; GEUSENS, Piet ; Pascale, Pellet; Delicha, Evie Marie; Pricop, Luminata; Mpofu, ShepardJournal ContributionM
Showing results 1 to 5 of 5